Market Challenges And Opportunities

Disposable Infusion Extension Lines Market Drivers:-

Major driver for growth of the global disposable infusion extension lines market is increasing blood donation campaigns. According to a survey conducted by World Health Organization (WHO), in 2015, more than 51.2 million people in India donate blood annually. The survey also reports that the need for blood donation camps have increased due to rise in road accidents. According to a survey conducted by Ministry of Road transport and highway in 2016, more than 60 million people are hospitalized and more than 150,785 people were killed due to road accidents. Increasing number of accidents can also contribute to the market growth.

The global disposable infusion extension lines market is expected to grow at significant rate due to increasing number of patient suffering from chronic diseases such as diabetes, cancer, and others. According to National Diabetes Statistics report 2017, by Center for Disease Control and Prevention (CDC), U.S. has more than 30.3 million diabetes patients. Out of this 25.5% are geriatric population who require hospitalization to maintain insulin in their body. Such significant rise of diabetic patients can help in growth of global disposable infusion extension lines market. According to a survey conducted by Organization for Economic Co-operation and Development (OECD) in 2016, more than 6.3 million people are hospitalized due to cardiovascular diseases and more than 3.1 million are hospitalized due to chronic diseases such as diabetes, cancer, and Chronic Obstructive Pulmonary Disease (COPD). According to a survey conducted by WHO in 2016, more than 3.2 million new cancer patients are reported in Europe annually. Therefore, increasing number of cardiovascular and chronic diseases is in turn driving growth of the disposable infusion extension lines market.

Infusion therapy is majorly performed at healthcare facilities such as hospitals, clinics and ambulatory surgery centers by trained professionals. This increases the overall cost per procedure, which is restraining the growth of the market.